Instagram story viewer> @mondaynightibd> Posts

MondayNightIBD

@mondaynightibd

2.1K

followers

589

following

Created by @dcharabaty Join us every Monday on twitter for #IBD #MedEd 🆓#CME #Back2Basics
#IBDPoll & convo
#PatientExperience

POSTS STORIES REELS TAGGED

⏳Don’t miss this Annual EduSocial event of #DDW26 w 🌟 Clinicians and Advocates faculty !

🤝Bridging The Communication Gap For Better #IBD Care: A Collaborative Approach

🤝Clinicians, patients, advocates, Let’s talk IBD unmet needs & collaborate for better IBD care !

🎯IBB care in the adolescent & transitioning of care from peds to adult GI: how can we do better?

🎯Diet and IBD: risk factors, triggers or medicine? Barriers & challenges to “healthy diet” in youth, in people with altered gut anatomy, in food deserts, in culturally diverse & more

📌Sunday May 2, 5-8pm,
🌅Mae District

📲🆓 Registration🔗 in bio (Registration is free but space limited !)

Connect Learn Educate and Collaborate in a friendly atmosphere !

#crohnsdisease #ulcerativecolitis #strongertogether PatientCenteredCare

@colorofgi @saia_ibd @ibdesis @blackingastro @connectingtocure @ibdmoms @menagastro RainbowInGI @ibdgirls @ccyanetwork

Grateful to our supporters !
@jnjinnovativemedicine @elilillyco @merck Takeda @abbvie @genentech @pfizerinc by @mondaynightibd

25

1

6 months ago

IBD-related stigma is one of the most significant challenges that hinders open conversations about IBD care.

Dr. Aline Charabaty (@dcharabaty), a gastroenterologist and contributing author of our white paper, “The Power of Community in IBD”, is a champion of creating safe spaces to foster well-rounded IBD care. She emphasizes the role care teams and providers play in destigmatizing IBD and creating supportive environments for patients.

Learn more about the role that stigma plays in IBD care and how supportive care teams can help in our white paper – link in bio. 🔗

#CrohnsDisease #UlcerativeColitis #InflammatoryBowelDisease #CrohnsAndColitis #IBDAwareness by @mondaynightibd

91

3

3 months ago

Join Dr. Vipul Jairath (@vipuljairath, Gastroenterologist & Professor of Medicine, Western University) and Tina Aswani-Omprakash (@ownyourcrohns, CEO of SAIA & #Crohns & #Ostomy Patient Advocate) this week as they join hands with @mondaynightibd on behalf of SAIA to discuss Clinical Trials & New IBD Therapies! 💥

‌On Monday, June 15th, Dr. Jairath will lead the discussion on X (Twitter) from the clinician perspective! And on Wednesday, June 17th, Tina will lead the discussion on X (Twitter) from the patient perspective! 👏🏽👏🏽

‌Whether you’re a physician or a patient, please do check out the polls on X (Twitter) and feel free to participate and share your thoughts and experiences. We welcome you all to join in and learn more: http://www.x.com/mondaynightibd ! 🙌🏽

#ownyourcrohns #clinicaltrials #IBD by @mondaynightibd

3

6

4 months ago

Back2Basics & #IBD Algo
🎯Very early onset IBD #Crohns #UlcerativeColitis #VEOIBD
With #DrDavidLevine @gut.md_ & @gutsglory.md

🧒🏻Definition: Age on onset <6
🔺Make up 15% of all PedsIBD
🧬~15-20% having a monogenic cause — especially infants <age 2
📈 VEO-IBD is on the rise

💎 Dz location: Colon ++ (94%); isolated ileal disease rare
🔬 Histology clues — eosinophilic infiltrates, ⬆️apoptosis; villous blunting/atrophy, ⬆️IEL — can point to monogenic disease
⏰💎All pts should get genetic evaluation

⏰⬇️ Response to TNFi in VEOIBD vs in older kids
✅ IFX 3-yr maintenance 12% VEOIBD vs 67% in REACH trial
💎 Recommendations to ⬆️ réponse to IFX:
✅ Body Surface Area-based dosing (200 mg/m²) + tight TDM
✅🎯 IFX levels: >23 before 2nd infusion, >10 @ maintenance

🧬Monogenic VEOIBD management
💎 Genetic mutation guides targeted therapy, identify CI to drugs
✅ Abatacept for CTLA4/LRBA deficiency
✅ Anti-IL18 for NLRC4
✅ Rapamycin for FOXP3/PIK3CD before HSCT
✅ Hematopoietic stem cell transplant
🚨💎Critical: AVOID TNFi in CGD
🚨💎Hematopoietic stem cell transplant is potentially curative !

Supported by educational grants @abbvie @jnjinnovativemedicine and Takeda Pharma by @mondaynightibd

32

0

4 months ago

Part2 🔥Optimizing your DDW (or any other large meeting) as a trainee interested in GI /GI Fellow / GI Fellow interested in IBD

💎Tips 💎Tricks from @arushikohli & @josephhabibi_md

🌟Don’t forget to have fun and make new friends ! Your professional network can become your friends network
🌟Don’t miss after hours #EduSocial events
✔️ @mondaynightibd X @colorofgi Saturday May 2 at Mae District
✔️ @menagastro Sunday May 3 at Barrio
✔️ @amergastroassn Women in GI luncheon Mon May 4
As well as ✔️ @saia.gi , @blackingastro #RainbowInGI events & more
🌟How to pre-arrange for a one-on-one meeting with a potential mentor
🌟How to leverage DDW connections when seeking an #IBD #Fellowship
🌟How to always be ready with an updated CV, contact info etc

⏳Watch until the end for Dr @arushikohli sharing a mistake she did at her first DDW & her advice ! by @mondaynightibd

30

0

6 months ago

Are you a trainee or a fellow interest in GI/IBD ?

DDW or other large meetings can be overwhelming and intimidating

@josephhabibi_md & @arushikohli share their 💎trips 💎tricks & 💎experience on how to optimize your DDW for

✔️#MedEd
✔️#Networking,
✔️Engaging research collaborators
✔️Advancing your career (residency ➡️GI ➡️ IBD fellowship )
✔️And have some fun & make new friends

Part 1
📲 Using the DDW app to plan your sessions
✔️Poster session: the less intimidating 🔥 place to be to learn, connect, develop collab
✔️Prepping and acing your poster presentation
✔️Networking: thinking of approaching a GI leader you admire for mentorship or collab? The do’s 👍🏼and don’t 👎🏼
✔️Social media: pearls on how to best to use it to educate others & create visibility for yourself; without going overboard !

Make sure to check out part2!

Made possible with the support of educational grants @abbvie @jnjinnovativemedicine & Takeda

#Fellowship #Residency #IBD by @mondaynightibd

52

0

6 months ago

Thought-provoking insights and questions during the #MondayNightIBD convo on #ASUC Acute Severe #UlcerativeColitis, led by @joshsteinbergmd

Masterfully summarized in this #IBDAlgorithm by @gutsglory.md

❓Why are we still waiting for IV corticosteroids failure on day 3 to start effective “rescue” therapy , when we know the patient will need an advanced therapy

❓Will JAKi (TOFA & UPA) replace TNFi as rescue therapy for ASUC: lower cost , easier to access in 🏥 & after discharge

❓Can we manage select patients with ASUC outside the 🏥 or in a HospitalAtHome setting with close monitoring

🔺Summary of guidelines in the algo, with a look into the future of ASUC managment
✔️IFX still most commonly used rescue therapy
✔️Choose JAKi if low albumin, no response or loss of response to IFX prior to ASUC
✔️Accessibility & cost might start favoring JAKi > IFX
✔️Consult surgery early on admission, & definitely if no response to IVCS on day 3 - ⚠️If patient needs surgery, don’t delay it ! Delay in surgery associated with increased post-op complications !

🌟#PatientExperience convo on the patient surgical journey led by @loriplung : what can clinicians do to help patients make the decision for surgery when they need it : ✔️Talk about surgery early & not as a “last resort” option, but as the best treatment option for the current situation ✔️Validate patients fears and answer patients questions over more than one visit if needed ✔️Explain to patient what to expect during post-op recovery and post surgical QOL ✔️ Connect the patient with a peer / advocate who had similar surgery (a great resource shared by Lori is the Power of 2 by @crohnscolitisfoundation ) by @mondaynightibd

43

1

7 months ago

🚨Acute Severe Ulcerative Colitis (ASUC) is a medical & surgical emergency 🚨ACT FAST

📌Admission, evaluation & therapies have to be done in a very timely manner
📌Patients’ condition can deteriorate quickly and require emergent surgery: monitor clinically + by labs + have the surgical team on board from the time of admission

🔥#MondayNightIBD #Back2Basics 🔥 by Drs Ifrah Fatima & Aimen Khan

✅Recognize ASUC -> 🏥
✅DO’s: Labs to order, stool for CDiff, flex sig with CM biopsie, DVT prophylaxis- Steroids & rescue therapy- Surgical consults
🚫DON’T: antibiotics, TPN, narcotics …

‼️CDiff doesn’t cause pseudomembranes in IBD patients: don’t rely on flex sig to make the diagnosis, check stool for CDiff

‼️If CDIFF + or CMV +: Treat the infection AND underlying ASUC
⚠️These patients are at higher risk of needing a colectomy ✂️

⏳If BM, blood, CRP do not ⬇️ by > 50% on day 3 of IV steroids -> Start Rescue therapy : IFX, CysA, JAKi, or Surgery

🔮Check predictors of steroids & IFX failure

💉IFX optimization (10mg/kg) & acceleration (infusions at 5 days interval x2-3) in ASUC: short-term benefit in select patients with high CRP, low albumin

✂️DONT delay surgery in the patient who needs it ! Delays = ⬆️ risk of op & post-op complications

#IBD #UlcerativeColitis #MedEdWithoutBorders by @mondaynightibd

49

0

7 months ago

💎#IBDAlgo by @gutsglory.md summarizing key point of the 💥convo led by @jordan_axelrad :

Approaching IBD therapy in a patient with #IBD , a new diagnosis of #cancer in need of immunotherapy

⚖️Optimize IBD control & minimize systemic immunosuppression & impact of IBD therapy on cancer progression
✅Preference goes to Vedolizumab & anti-IL23, but if anti-TNF is needed as a MOA it should be considered

🚫Which therapy to stop by type of cancer?
🔺Lymphoma: ✋🏽thiopurines & anti-TNF
🔺Other heme malignancies: ✋🏽 thiopurines
🔺Melanoma: ✋🏽anti-TNF
🔺Recurrent SCC: ✋🏽 thiopurines
🔺Solid organ CA: ✋🏽thiopurines if cervical or urinary tract CA

✅Otherwise: OK to continue other biologics (Vedo, UST, IL23)

💉Effect of cancer therapies on IBD
🔺Cytotoxic chemotherapy
⚠️can put IBD in remission for few years (and ok to hold off IBD immunosuppressants )
🔺#Immunotherapy/ Immune check point inhibitor
⚠️can lead to ICI-colitis (that mimics IBD) & risk is higher in patients with IBD
⚠️treat early with IFX or Vedo (similar efficacy; Vedo might have an advantage on progression free/ overall survival)
⚠️High dose steroids at ICI-colitis dx can also decrease progression free/ overall survival

📣Patients with IBD: wear sunscreen & get an annual total body skin check : IBD increase the risk of melanoma regardless of therapy

📣MDs: enroll patients with IBD & CA in the SAPPHIRE registry so we can better understand how to care for our patients

#MedEdWithoutBorders

@nyulangone @mountsinaigi @mountsinainyc @helmsleytrust by @mondaynightibd

39

1

8 months ago

Kicking off 2026 with a #Back2Basics review of #IBD & #cancer @daniyal8540 @gutsglory.md

🔺IBD inflammation-driven GI malignancies
✔️Colon cancer in colonic disease involving more than 1/3 of the colon (start colonoscopy surveillance after 7-8yrs of IBD; start at diagnosis in IBD+PSC)
✔️Small bowel cancer in SB crohns
✔️Anal cancer in perianal crohns : anal squamous cell & mucinous adenoCA that can arise in fistula ⚠️
✔️CholangioCA in PSC

🔺IBD therapies-associated malignancies
✔️Thiopurines→ lymphoma, urinary CA (men > age 50), NMSC
✔️Anti-TNF mono → low risk of lymphoma
✔️Combo thiopurines+ anti-TNF → highest risk for lymphoma
✔️JAKi: signal for lymphoma/lung/NMSC
✔️5ASA, Vedo : no malignancy risk
✔️IL23: no signal so far

🔺Knowledge Pearls
💎Relative risk ≠ absolute risk: when a malignancy is rare in the general population, it still remains uncommon in patients at higher risk
💎Risk of lymphoma is mainly driven by thiopurines (& increased by adding anti-TNF)
💎Most common type of lymphoma w thiopurine is EBV-associated post-transplant like: ⬆️ risk after >1-2 yrs of use, mainly in men > age 50, risk goes back down to that of general population after discontinuation
👉🏽 avoid use in men > age 50; stop it after 1-2 yrs of use in patients on combo anti-TNF + thiopurines if possible (⚖️ risks & benefits of combo therapy)
💎Learn about the other 2 rare (but poor prognosis) types of thiopurines-associated lymphomas in men < age 35 (in slides)
💎IBD patients are at higher risk of melanoma, regardless of therapies ➡️ use sunscreen 🧴& annual skin check

#Crohns #UlcerativeColitis MedEd by @mondaynightibd

102

0

9 months ago

🌟 Meet our Vice-President and Member of the Board At-Large! 🌟

Aline Charabaty, MD, AGAF, FACG, is a professor of Medicine and the Director of the IBD Center at the University of Maryland. She’s also the founder of @MondayNightIBD and the co-founder of Scrubs & Heels.

Dr Charabaty brings her expertise, enthusiasm, and dedication to EBMed, ensuring that integrity and compassion are at the heart of everything we do.

EBMed is a nonprofit 501(c)(3) educational organization dedicated to: (1) improving GI patient care through continuing education utilizing evidence-based medicine principles; and (2) advancing the careers of women, first-generation college graduates, and underrepresented minorities in GI careers through mentorship and sponsorship opportunities.

EBMed’s GI Debates is a hybrid meeting that combines CME with networking/mentoring activities for GI trainees. The 2026 Great GI Debates is Feb 6 - 8 at the Westin Fort Lauderdale Beach Hotel in Fort Lauderdale, Florida.

Learn more at https://ebmed.net

#IBD #GutHealth #Gastroenterology #EsophagealDisorders #GIMotility EBMed2026 EBMed by @mondaynightibd

84

11

9 months ago

Join our next @yogi_ibd
webinar
"The best of IBD @uegweek
Berlin 2025"

⌛️Tuesday December 16th 4 pm Spain/Norway / US East 10:00 / 8:30 pm India

Link in bio

Join the conversation!!!
Speakers: Dr Luisa Bertin
🇮🇹🇧🇷 Dr Esteban Fuentes

🇪🇸🇨🇱 @dr.beatrizgros
Dr Nacho Catalan by @mondaynightibd

71

1

10 months ago